ClearSight Therapeutics
ClearSight Therapeutics is a Dallas-based biotech company founded in 2023 by eye care industry veterans. The company is dedicated to developing innovative, over-the-counter (OTC) solutions for common eye conditions such as dry eye and pink eye (acute infectious conjunctivitis). With a mission to disrupt the traditional OTC eye care industry, ClearSight leverages a proprietary platform that combines the dual-action potency of leading artificial tears and a powerful antimicrobial biopolymer. Their vision is to provide safe, effective, and accessible treatments that put patients first, while upholding ethical and responsible research and development practices.
Industries
Nr. of Employees
small (1-50)
Products
OTC topical drop for acute infectious conjunctivitis (pink eye)
An over-the-counter topical eye drop described as combining a lubricant with an antimicrobial biopolymer to reduce redness, swelling, and discomfort associated with acute infectious conjunctivitis.
OTC dry eye therapeutic drops
Over-the-counter topical formulation aimed at treating dry eye disease using a lubricant-based approach within the company's platform.
Contact lens rewetting drops
Topical rewetting drop formulations intended to rehydrate contact lenses and provide ocular comfort.
OTC topical drop for acute infectious conjunctivitis (pink eye)
An over-the-counter topical eye drop described as combining a lubricant with an antimicrobial biopolymer to reduce redness, swelling, and discomfort associated with acute infectious conjunctivitis.
OTC dry eye therapeutic drops
Over-the-counter topical formulation aimed at treating dry eye disease using a lubricant-based approach within the company's platform.
Contact lens rewetting drops
Topical rewetting drop formulations intended to rehydrate contact lenses and provide ocular comfort.
Services
End-to-end development of over-the-counter topical eye drop products using a dual-action platform that combines ocular lubricants with antimicrobial biopolymers.
End-to-end development of over-the-counter topical eye drop products using a dual-action platform that combines ocular lubricants with antimicrobial biopolymers.
Expertise Areas
- Ophthalmic formulation development
- OTC product development
- Clinical trial management and drug development
- Biomaterials for ocular use
Key Technologies
- Antimicrobial biopolymers
- Artificial tear / ocular lubricant formulations
- Topical ophthalmic (eye drop) delivery
- Contact lens rewetting formulation